Company Pay Ratios
Publicly traded companies are required to disclose the pay ratio between their chief executive officers and median employees. High CEO-to-worker pay ratios contribute to economic inequality and can undermine employee morale and productivity. The average S&P 500 company’s CEO-to-worker pay ratio was 272-to-1 in 2022.
| Ticker | Company | Median Worker Pay Sort ascending | Pay Ratio |
|---|---|---|---|
| SSSS | Suro Capital Corp. | $358,757 | 12:1 |
| CTRE | Caretrust Reit, Inc. | $357,364 | 11:1 |
| OLP | One Liberty Properties Inc. | $348,690 | 6:1 |
| DHIL | Diamond Hill Investment Group Inc. | $346,450 | 12:1 |
| CIM | Chimera Investment Corp. | $345,000 | 17:1 |
| CPRX | Catalyst Pharmaceuticals, Inc. | $343,631 | 20:1 |
| OWL | Blue Owl Capital Inc. | $342,507 | 30:1 |
| KYMR | Kymera Therapeutics, Inc. | $341,869 | 20:1 |
| RPRX | Royalty Pharma PLC | $337,085 | 277:1 |
| NLY | Annaly Capital Management Inc. | $335,000 | 43:1 |
| LADR | Ladder Capital Corp. | $325,885 | 38:1 |
| EQS | Equus Total Return, Inc. | $325,746 | 3:1 |
| INVA | Innoviva, Inc. | $319,745 | 6:1 |
| CERE | Cerevel Therapeutics Holdings, Inc. | $318,973 | 35:1 |
| GPMT | Granite Point Mortgage Trust Inc. | $318,450 | 12:1 |
| SNDX | Syndax Pharmaceuticals Inc. | $316,414 | 13:1 |
| RBLX | Roblox Corp. | $315,140 | 4:1 |
| SNOW | Snowflake Inc. | $314,471 | 75:1 |
| RARE | Ultragenyx Pharmaceutical Inc. | $314,351 | 39:1 |
| ARQT | Arcutis Biotherapeutics, Inc. | $310,773 | 15:1 |
NOTE: For companies with more than one CEO during the year, the highest-paid CEO is included in the database. Pay ratio between CEO pay and median employee pay are displayed as disclosed by each company’s proxy statement. The CEO pay ratio may not equal the displayed CEO’s total compensation due to differing company methodologies in calculating pay ratios.
Terms and Data Sources | Contact the Press Office